HYALINE OCCLUSIVE GLOMERULAR MICROANGIOPATHY

This adverse event was reported 20 times

These drugs are most commonly taken by patients reporting HYALINE OCCLUSIVE GLOMERULAR MICROANGIOPATHY:

# Drug Count
0 BEVACIZUMAB 17
1 ACETAMINOPHEN 1
2 ACETAMINOPHEN 500MG 1
3 ACETAMINOPHEN TABLET EXTENDED RELEASE 1
4 AVATROMBOPAG MALEATE 1
5 CARBOPLATIN 1
6 DOCUSATE SODIUM 1
7 DOCUSATE SODIUM - SENNOSIDES 1
8 FENTANYL 1
9 LENVATINIB 1
See all common drugs associated with HYALINE OCCLUSIVE GLOMERULAR MICROANGIOPATHY

HYALINE OCCLUSIVE GLOMERULAR MICROANGIOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AVATROMBOPAG MALEATE 1 0.0004
1 BEVACIZUMAB 17 0.0001
2 LENVATINIB 1 0.0000
3 TAPENTADOL HYDROCHLORIDE 1 0.0000
4 DOCUSATE SODIUM 1 0.0000
5 FENTANYL 1 0.0000
6 PACLITAXEL 1 0.0000
7 CARBOPLATIN 1 0.0000
8 PREGABALIN 1 0.0000
9 ACETAMINOPHEN 1 0.0000
See all drugs enriched for association with HYALINE OCCLUSIVE GLOMERULAR MICROANGIOPATHY

HYALINE OCCLUSIVE GLOMERULAR MICROANGIOPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Vascular Endothelial Growth Factor Inhibitor [EPC] 17 0.0001
1 Microtubule Inhibitor [EPC] 1 0.0000
2 Opioid Agonist [EPC] 1 0.0000
3 Platinum-based Drug [EPC] 1 0.0000
4 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with HYALINE OCCLUSIVE GLOMERULAR MICROANGIOPATHY